U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225634) titled 'A Study of Combogesic(R) IV (Intravenous) in Pediatric Patients With Acute Pain' on Oct. 30.
Brief Summary: Combogesic(R) IV is an intravenous medicine (given by vein) containing a combination of two pain relief (analgesic) medicines called ibuprofen and acetaminophen. The goal of this clinical trial is to study the way that the body processes and clears the intravenous infusion of Combogesic(R) IV and that it is safe to be used in children and adolescents between the ages of 2 and <17 years.
What will the study involve for participants?
* Combogesic(R) IV will be administered every 6 hours as necessary with a maximum of 4 doses wi...